Skip to main content
. Author manuscript; available in PMC: 2019 Nov 28.
Published in final edited form as: J Control Release. 2018 Oct 2;290:75–87. doi: 10.1016/j.jconrel.2018.09.025

Fig. 8.

Fig. 8.

Representative images of H&E staining of the intestine from mice treated with (a) PBS, (b) LGK974, (c) HPβCD:LGK974, or (d) βSBECD:LGK974 complexes at high dosages of 10mg/kg/d over 7days (Magnification: duodenum, 20×.Scale bars: 20×−100 μm. (e) Scoring for intestinal mucosal damage. *** P < .001 compared to the LGK974 group.